Jan 30, 2025, 19:23
Estela Rodriguez: A diagnostic shift from static biomarker quantification to assessing active immune pathways
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared an article on X authored by Amanda Lindberg et al.:
“This study proposes a diagnostic shift from static biomarker quantification in pts with NSCLC to assessing active immune pathways to provide more precise ICI treatment. Ultimately, the results implicate a need for combination diagnostics and therapies.”
Authors: Amanda Lindberg et al.
Amanda Lindberg
Artur Mezheyeuski
cancer
Carina Strell
Cecilia Lindskog
Erika Broström
Estela Rodriguez
Hans Brunnström
Hui Yu
Jakob Friedrich
Johan Botling
Johan Isaksson
Johanna Mattsson
Klas Kärre
Lars Muhl
Louise Hellberg
Max Backman
Miklos Gulyas
Neda Hekmati
NSCLC
OncoDaily
Oncology
Patrick Micke
Rebecca Artursson
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 30, 2025, 19:22
Jan 30, 2025, 18:32
Jan 30, 2025, 18:20